World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 23 October 2023
Main ID:  NCT03350516
Date of registration: 19/11/2017
Prospective Registration: Yes
Primary sponsor: Harvard School of Public Health (HSPH)
Public title: Non-inferiority of Lower Dose Calcium Supplementation During Pregnancy
Scientific title: Demonstrating Non-inferiority of Lower Dose Calcium Supplementation During Pregnancy for Reducing Preeclampsia and Neonatal Outcomes
Date of first enrolment: November 30, 2018
Target sample size: 22000
Recruitment status: Completed
URL:  https://clinicaltrials.gov/ct2/show/NCT03350516
Study type:  Interventional
Study design:  Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Prevention. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).  
Phase:  Phase 3
Countries of recruitment
India Tanzania
Contacts
Name:     Wafaie W Fawzi, MBBS, DrPH
Address: 
Telephone:
Email:
Affiliation:  Harvard School of Public Health (HSPH)
Key inclusion & exclusion criteria

Inclusion Criteria:

- Nulliparous

- Attending first ANC visit at study clinics

- Pregnant women <20 weeks

- = 18 years old

- Intending to stay in study area until 6 weeks post delivery

- Provides informed consent

Exclusion Criteria:

- History or signs and/or symptoms of nephrolithiasis

- Prior diagnosis of parathyroid disorder or thyroidectomy

- Diseases that require digoxin, phenytoin, or tetracycline therapy



Age minimum: 18 Years
Age maximum: N/A
Gender: Female
Health Condition(s) or Problem(s) studied
Pregnancy Related
Intervention(s)
Dietary Supplement: Daily 500 mg elemental calcium as calcium carbonate
Dietary Supplement: Daily1500 mg elemental calcium as calcium carbonate
Primary Outcome(s)
Proportion of pregnant women with incident preeclampsia [Time Frame: Gestational week 20 to Delivery]
Proportion of preterm birth [Time Frame: Birth]
Secondary Outcome(s)
Secondary ID(s)
OPP1172660
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
St. John's Research Institute
Africa Academy for Public Health
Ifakara Health Institute
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history